World

An experimental coronavirus vaccine developed by Johnson & Johnson protected monkeys from infection in a new study. He is the second vaccine candidate to show promising results in monkeys this week. The company recently began a clinical trial in Europe and the United States to test its vaccine on people. …

meIt is three in the afternoon, and I am pushing the lifeless body of a sedated crocodile onto a swampy shoreline. My character’s stamina is about to run out, and then I’ll drown, and by the time it reappears, my scaly friend will be awake, ready to criticize me for …

Text size fake pictures Shares of AstraZeneca rose on Thursday as new drug sales helped the British pharmaceutical giant exceed expectations in the second quarter. Late-stage trials for its experimental coronavirus vaccine, developed with the University of Oxford, have also begun in the UK, Brazil and South Africa, the company …

TOKYO (AP) – Asian stocks fell on Friday when reports showed layoffs of US workers persist at high levels after the US economy contracted at an annual rate of nearly 33% in the spring, the worst quarter on record. The earnings reports, an indicator of how well companies are handling …

NEW BRUNSWICK, NJ, July 30, 2020 / PRNewswire / – Johnson & Johnson (NYSE: JNJ) (the Company) announced today that its leading vaccine candidate protects against infection with SARS-CoV-2, the virus that causes COVID-19, in preclinical studies. The data, published in Nature, show that the Company’s investigational adenovirus vector-based vaccine …